Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 11/20 | 0.49 |
| ▸ | MAPK9 | P45984 | 9/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.41 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6114117 | 0.87 | MAPK10 (0.42) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL14329649 | 0.86 | MAPK10 (0.42) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL26329874 | 0.84 | KDM4E (0.40) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL17349393 | 0.84 | KDM4E (0.43) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL17348982 | 0.84 | MAPK10 (0.43) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL26329797 | 0.84 | KDM4E (0.43) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL26329869 | 0.84 | KDM4E (0.40) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL26329798 | 0.84 | KDM4E (0.43) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL6114327 | 0.84 | MAOA (0.43) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL16452011 | 0.83 | MAOA (0.38) | MAPK10MAPK9CYP19A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163411-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163411-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR | WEE1, WEE2, ALOX12 | MAPK10 2007/4885MAPK9 1108/4885CYP19A1 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.